RPMI-1640完全培养基(含10% FBS)
货号: PM150110B
Price:
¥350.00
¥450
产品信息
产品简介 | RPMI-1640是Moore等人于1967年在美国纽约州法罗市的罗斯韦尔公园纪念研究所(RoswellParkMemorialInstitute,RPMI)开发出来的,RPMI是该研究所开发的一类细胞培养基,1640是培养基代号。RPMI-1640是改进型的McCoy's5A培养基,使用碳酸氢盐缓冲系统,与大多数哺乳动物细胞培养基不同的是其典型的PH8的配方。RPMI-1640培养基最初是为淋巴细胞培养专门设计的,现在已广泛应用于各种正常细胞和癌细胞的培养,尤其是悬浮细胞的培养,是使用最为广泛的培养基之一。 |
产品形态 | 液体 |
产品浓度 | 1× |
产品规格 | 125mL×4 |
PH | 7.4-7.8 |
细菌检测 | Negative |
真菌检测 | Negative |
支原体检测 | Negative |
细胞生长实验 | The cells are growing well and exhibit normal morphology. |
内毒素含量(EU/mL) | <3 |
储存条件 | 2-8℃,避光储存 |
运输条件 | 冰袋运输 |
有效期 | 6个月 |
注意事项 |
|
-
Construction and validation of a diagnostic model for cholangiocarcinoma based on tumor-educated platelet RNA expression profiles(2025)
作者:Haiyang Hu, Jiefeng He, Haoliang Zhao
期刊:Oncologie
DOI:10.1515/oncologie-2024-0520
影响因子:1.4
引用产品: RPMI-1640完全培养基(含10% FBS), DMEM高糖 培养基, 特级胎牛血清
-
N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2(2024)
作者:Wen Diguang, Xiao Hang, Gao Yueyi, Zeng Hanqing, Deng Jianchuan
期刊:Molecular Cancer
DOI:10.1186/s12943-024-02013-y
影响因子:27.7
引用产品: 293T [HEK-293T] 细胞, HL-60 细胞, THP-1 细胞, NB4 细胞, DMEM高糖完全培养基(含10% FBS), IMDM完全培养基(含10% FBS), RPMI-1640完全培养基(含10% FBS)
-
The Scutellaria-Coptis herb couple and its active small-molecule ingredient wogonoside alleviate cytokine storm by regulating the CD39/NLRP3/GSDMD signaling pathway(2024)
作者:Huan Wang, Yuejia Lan, Liuling Luo, Yang Xiao, Xianli Meng, Yong Zeng, Jiasi Wu
期刊:JOURNAL OF ETHNOPHARMACOLOGY
影响因子:5.4
引用产品: RAW 264.7 细胞, DMEM高糖完全培养基(含10% FBS), THP-1细胞专用培养基, RPMI-1640完全培养基(含10% FBS), RAW 264.7细胞专用培养基, THP-1 细胞
-
Mechanism of norcantharidin intervention in gastric cancer: analysis based on antitumor proprietary Chinese medicine database, network pharmacology, and transcriptomics(2024)
作者:Zhai Yiyan, Zhang Fanqin, Zhou Jiying, Qiao Chuanqi, Jin Zhengsen, Zhang Jingyuan, Wu Chao, Shi Rui, Huang Jiaqi, Gao Yifei, Guo Siyu, Wang Haojia, Chai Keyan, Zhang Xiaomeng, Wang Tieshan, Sheng Xiaoguang, Liu Xinkui, Wu Jiarui
期刊:Chinese Medicine
DOI:10.1186/s13020-024-01000-1
影响因子:5.3
引用产品: RPMI-1640完全培养基(含10% FBS)
-
Hsa_circRNA_000166 accelerates breast cancer progression via the regulation of the miR-326/ELK1 and miR-330-5p/ELK1 axes(2024)
作者:Ming-Hui Wang, Zi-Hui Liu, Hong-Xu Zhang, Han-Cheng Liu, Li-Hui Ma
期刊:ANNALS OF MEDICINE
DOI:10.1080/07853890.2024.2424515
影响因子:4.9
引用产品: 特级胎牛血清, RPMI-1640完全培养基(含10% FBS)
-
Glabridin inhibits proliferation and migration in hepatocellular carcinoma by regulating multi-targets(2024)
作者:Fei Wang, Chong Yuan, Yi Lu, Mojiao Wu, Hezhen Wu, Yifei Liu, Yanfang Yang
期刊:JOURNAL OF ETHNOPHARMACOLOGY
影响因子:4.8
引用产品: RPMI-1640完全培养基(含10% FBS), HuH-7 细胞, Hep G2 细胞, HuH-7细胞专用培养基
-
Artesunate-loaded solid lipid nanoparticles resist esophageal squamous cell carcinoma by inducing Ferroptosis through inhibiting the AKT/mTOR signaling(2024)
作者:Yu Xia, Yixin Tang, Zhixin Huang, Nantian Ke, Yue Zheng, Wanzhen Zhuang, Yi Zhang, Xiaoqing Yin, Mingshu Tu, Jianlin Chen, Yingshu Wang, Yi Huang
期刊:CELLULAR SIGNALLING
DOI:10.1016/j.cellsig.2024.111108
影响因子:4.8
引用产品: KYSE-150 细胞, KYSE-30 细胞, 人食管上皮细胞, RPMI-1640完全培养基 (含10%FBS)
-
Research on the potential mechanism of Deapioplatycodin D against pulmonary fibrosis based on bioinformatics and experimental verification(2024)
作者:Chao Li, Aliya Abdurehim, Shuang Zhao, Qing Sun, Jiawen Xu, Junbo Xie, Yanqing Zhang
期刊:EUROPEAN JOURNAL OF PHARMACOLOGY
DOI:10.1016/j.ejphar.2024.176603
影响因子:4.2
引用产品: BEAS-2B 细胞, RPMI-1640完全培养基(含10% FBS)
-
Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer(2024)
作者:Xinli Liu, Wenyi Wang, Bing Chen, Shengjie Wang
期刊:Aging-US
影响因子:3.9
引用产品: MCF7 [MCF-7]细胞专用培养基, BT-474 [BT474]细胞专用培养基, T-47D细胞专用培养基, MDA-MB-453细胞专用培养基(L15), MDA-MB-231/GFP细胞专用培养基(L15), MCF 10A细胞专用培养基, RPMI-1640完全培养基(含10% FBS)
-
Role and mechanism of COL3A1 in regulating the growth, metastasis, and drug sensitivity in cisplatin-resistant non-small cell lung cancer cells(2024)
作者:Jiankun Ren, Songwei Zhao, Junyu Lai
期刊:CANCER BIOLOGY & THERAPY
DOI:10.1080/15384047.2024.2328382
影响因子:3.6
引用产品: A549 [A-549] 细胞, NCI-H460 [H460] 细胞, Ham's F-12K完全培养基 (含10%FBS), RPMI-1640完全培养基 (含10%FBS), HBE cell, A549/DDP 细胞

识别码示意图